A health worker takes a mouth swab sample of a boy to test for COVID-19 in Hyderabad, India, Thursday, April 29, 2021. (AP Photo/Mahesh Kumar A.) Workers unload a shipment of Moderna COVID-19 vaccines at the FedEx hub in Toronto, Wednesday, April 28, 2021. (Cole Burston/The Canadian Press via AP) A Nepalese woman walks on a deserted street during the first day of lockdown in Kathmandu, Nepal, Thursday, April 29, 2021. Offices were closed, markets were shuttered and vehicles were forced off the street in Nepal's capital on Thursday as authorities imposed a 15-day lockdown because of spiking cases of COVID-19 in the country. (AP Photo/Niranjan Shrestha) South Korean Olympic judo team player An Ba-ul receives the first dose of the Pfizer-BioNTech COVID-19 coronavirus vaccine at the National Medical Center Thursday, April 29, 2021, in Seoul, South Korea. South Korea has begun administering fast-track COVID-19 vaccines to athletes, coaches and others expected to attend the Tokyo Olympics this summer.(Chung Sung-Jun/Pool Photo via AP) Wearing masks and paper suits to curb the spread of the new coronavirus, people protest demanding the government's help in resolving their housing problems, in front of the Ministry of Housing in Santiago, Chile, Wednesday, April 28, 2021. (AP Photo/Esteban Felix) Cemetery workers carry the coffin of a COVID-19 victim to his grave during a nighttime funeral at the Vila Formosa cemetery in Sao Paulo, Brazil, Wednesday, April 28, 2021. (AP Photo/Nelson Antoine) A family that tested positive for COVID-19 poses at the door of their home in Belen, Uruguay, Wednesday, April 28, 2021. (AP Photo/Matilde Campodonico) A government worker wearing a protective suit disinfects the shoes of his colleague outside a COVID-19 testing site to curb the spread of the coronavirus in Quezon city, Philippines on Thursday, April 29, 2021. The Philippines is extending an already monthlong lockdown by two weeks as the country's worst coronavirus infection spike starts to ease but remains alarming. (AP Photo/Aaron Favila)
NAIROBI, Kenya — Africa’s top public health official says the continent is “watching with total disbelief” what is happening in India as it struggles with a devastating resurgence in COVID-19 cases.
Africa Centers for Disease Control and Prevention Director John Nkengasong warned that the African continent, which has roughly the same population as India and fragile health care systems, “must be very, very prepared” because it could see the same scenario now unfolding in the South Asian country.
“We need to regroup urgently,” Nkengasong told reporters Thursday.
“We do not have enough health care workers. We do not have enough oxygen,” he said.
Nkengasong also urged African nations to prevent mass gatherings including political rallies.
Africa’s vaccine situation is also closely linked to India, the source of the AstraZeneca vaccines distributed by the global COVAX project to get doses to low- and middle-income countries.
The vaccine export ban India adopted while coping with devastating domestic outbreaks “has severely impacted the predictability of the rollout of vaccination programs and will continue to do so for the coming weeks and perhaps months,” Nkengasong said, adding that if India can’t meet its own needs he doesn’t know how it can export doses to Africa.
Just 17 million vaccine doses have been administered across the African continent, he said, for a population of some 1.3 billion.
___
THE VIRUS OUTBREAK:
— Biden declared “America is rising anew” as he called for expanding programs to drive economy past pandemic
— India sets another record with new cases as it gears up to expand vaccinations to all adults
— As many as one-third of Mexicans may have been exposed to virus in 2020, blood tests indicate
___
— Follow more of AP’s pandemic coverage at https://apnews.com/hub/coronavirus-pandemic and https://apnews.com/hub/coronavirus-vaccine
___
HERE’S WHAT ELSE IS HAPPENING:
MADRID - More than 40 nongovernmental organizations are urging Spanish authorities to ensure that homeless people and migrants without authorization to be in Spain aren’t left out of the country’s COVID-19 vaccination plans.
The groups, which include Amnesty International, said they sent a letter to Health Minister Carolina Dias on Thursday asking for the urgent adoption of promised legislation that would plug gaps in Spain's mass vaccination program.
They say people without the social security cards needed to register for vaccine shots risk being left out, though the organizations acknowledged that some regional governments have taken local steps to address the problem.
Ensuring the equitable, non-discriminatory distribution of COVID-19 vaccines has been an issue in many parts of the world during the pandemic.
___
LISBON, Portugal -- The head of the World Health Organization says more than 1 billion doses of COVID-19 vaccines have been administered globally but 82% of them were given in high- and upper-middle-income countries.
WHO Director-General Tedros Adhanom Ghebreyesus says just 0.3% of all vaccines administered so far were given to people in low-income countries.
“That’s the reality,” Tedros told an online health conference hosted by Portugal on Thursday.
He said access to vaccines “is one of the defining challenges of the pandemic” and that public health is “the foundation of social, economic and political stability.”
___
BERLIN — German pharmaceutical company BioNTech says it expects to receive the results of trials of its coronavirus vaccine in younger children by September.
BioNTech, which developed the first widely approved COVID-19 shot with U.S. partner Pfizer, has already submitted data from trials in children ages 12-15 to the U.S. Food and Drug Administration and plans to do so for the European Medicines Agency, which regulates drugs for use in the 27-nation European Union. .
The company said it expects results from trials in children ages 5-12 “as early as July” and in those younger than 5 in September.
BioNTech said requests for regulatory approval would depend on the results of the trials.
The company is one of the main suppliers of coronavirus vaccines in Europe and North America.
___
SEOUL, South Korea — South Korea has begun administering fast-track COVID-19 vaccines to athletes, coaches and others expected to attend the Tokyo Olympics.
The Korean Sport & Olympic Committee says about 100 people received the first doses at a state-run Seoul hospital on Thursday, the first day of the country’s prioritized vaccination program for its Olympic delegation.
The committee says a total of 930 players, coaches, officials and other support staff will be given either Pfizer or AstraZeneca vaccines ahead of the Tokyo Games set to begin in July.
Athletes can receive the vaccines if they have already secured berths at the Olympics or may do so in qualification tournaments. This means some may get vaccinated who don’t go to the Games.
South Korea aims to send about 800-900 people to the Olympics, 350 of them athletes and coaches in 27 events. Committee officials expect to finalize the Olympic delegation in late June when all qualifying tournaments are finished.
The Sports Ministry says about 150 athletes and coaches hoping to attend the Tokyo Paralympics will separately get virus shots on Friday and May 4. Those also include athletes who are still under qualifying events.
__
KATHMANDU, Nepal — Offices were closed, markets were shuttered and vehicles were forced off the streets in Nepal’s capital on Thursday as authorities imposed a 15-day lockdown because of spiking cases of COVID-19.
The lockdown was imposed in most of the Himalayan nation’s major cities and towns. In Kathmandu and surrounding districts, police set up checkpoints and were stopping drivers and pedestrians. Several vehicles were impounded for defying the lockdown.
Residents rushed to neighborhood grocery stores for supplies in the morning when authorities allowed them to open for a few hours. Tens of thousands of people had rushed out of Kathmandu in the past two days to avoid the shutdown.
Both international and domestic flights were operating on schedule. The government has closed the land borders to foreigners, but citizens of neighboring India can enter with a negative coronavirus test and proof of a hotel booking for a 10-day quarantine.
Nepal’s health ministry has recorded 312,699 infections while 3,211 people have died from COVID-19.
___
CAMBRIDGE, Mass. — Moderna announced Thursday it is beefing up global manufacturing of its COVID-19 vaccine in an effort to produce up to 3 billion doses in 2022.
The company predicts supplying between 800 million and 1 billion doses worldwide this year. But it’s looking ahead as much of the world still will need a first round of COVID-19 vaccinations next year — and to be ready if and when people may need a booster shot.
Moderna’s vaccine is authorized for use by adults in the U.S., European Union and multiple other countries. The company expects data soon from a U.S. study of the two-dose vaccine in 12- to 17-year-olds, and has begun testing the shots in younger children. Also underway are studies of doses tweaked to better match a worrisome mutated version of the coronavirus.
___
MANILA, Philippines — The Philippines is extending an already monthlong lockdown by two weeks as the country’s worst coronavirus infection spike starts to ease but remains alarming.
President Rodrigo Duterte said in televised remarks Thursday night that the second-most restrictive lockdown level will now run through May 14 in metropolitan Manila and four nearby provinces, a region of more than 25 million people. Mayors, however, cut a nine-hour night curfew in metropolitan Manila to six hours to help battered businesses.
Duterte is warning mayors and village chiefs that they face jail if they don’t prevent gatherings and other events that violate the pandemic restrictions.
Confirmed coronavirus infections in the Philippines soared past 1 million Monday, with deaths now at more than 17,000, the second highest in Southeast Asia.
Before you consider Pfizer, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Pfizer wasn't on the list.
While Pfizer currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.
Get This Free Report